Figure 2From: Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection Therapeutic efficacy of WNIG. Groups of 5-week old BALB/c mice were treated i.p. with 2 mg/mouse IVIG-IL or WNIG on days 2 and 4, or days 3 and 5 after infection with 10 LD50 of West Nile virus. Mice were observed for mortality for 21 days. One group of infected mice received no treatment (control).Back to article page